95 related articles for article (PubMed ID: 31996318)
1. Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma.
Ishikawa C; Senba M; Mori N
Eur J Pharmacol; 2020 Apr; 872():172953. PubMed ID: 31996318
[TBL] [Abstract][Full Text] [Related]
2. Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol.
Ishikawa C; Tafuku S; Kadekaru T; Sawada S; Tomita M; Okudaira T; Nakazato T; Toda T; Uchihara JN; Taira N; Ohshiro K; Yasumoto T; Ohta T; Mori N
Int J Cancer; 2008 Dec; 123(11):2702-12. PubMed ID: 18798263
[TBL] [Abstract][Full Text] [Related]
3. Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells.
Mao L; Deng G; Li M; Lu SH; Jiang W; Yu X
Eur J Med Res; 2024 May; 29(1):293. PubMed ID: 38773551
[TBL] [Abstract][Full Text] [Related]
4. Fucoidan extracted from Cladosiphon okamuranus Tokida induces apoptosis of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
Haneji K; Matsuda T; Tomita M; Kawakami H; Ohshiro K; Uchihara JN; Masuda M; Takasu N; Tanaka Y; Ohta T; Mori N
Nutr Cancer; 2005; 52(2):189-201. PubMed ID: 16201850
[TBL] [Abstract][Full Text] [Related]
5. Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL).
Xu X; Kalac M; Markson M; Chan M; Brody JD; Bhagat G; Ang RL; Legarda D; Justus SJ; Liu F; Li Q; Xiong H; Ting AT
Cell Death Dis; 2020 Feb; 11(2):94. PubMed ID: 32024820
[TBL] [Abstract][Full Text] [Related]
6. Illuminating (HTLV-1)-induced adult T-cell leukemia/lymphoma transcriptomic signature: A systems virology approach.
Forghani-Ramandi MM; Mostafavi B; Bahavar A; Dehghankar M; Siami Z; Mozhgani SH
Virus Res; 2023 Dec; 338():199237. PubMed ID: 37832654
[TBL] [Abstract][Full Text] [Related]
7. Artesunate shows potent anti-tumor activity in B-cell lymphoma.
Våtsveen TK; Myhre MR; Steen CB; Wälchli S; Lingjærde OC; Bai B; Dillard P; Theodossiou TA; Holien T; Sundan A; Inderberg EM; Smeland EB; Myklebust JH; Oksvold MP
J Hematol Oncol; 2018 Feb; 11(1):23. PubMed ID: 29458389
[TBL] [Abstract][Full Text] [Related]
8. Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia.
Ishikawa C; Mori N
Eur J Haematol; 2024 Apr; ():. PubMed ID: 38558052
[TBL] [Abstract][Full Text] [Related]
9. Whole-genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in adult T-cell leukemia/lymphoma.
Chiba M; Shimono J; Suto K; Ishio T; Endo T; Goto H; Hasegawa H; Maeda M; Teshima T; Yang Y; Nakagawa M
Blood; 2024 Apr; 143(14):1379-1390. PubMed ID: 38142436
[TBL] [Abstract][Full Text] [Related]
10. The Novel Link between Gene Expression Profiles of Adult T-Cell Leukemia/Lymphoma Patients' Peripheral Blood Lymphocytes and Ferroptosis Susceptibility.
Wang Y; Iha H
Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002949
[TBL] [Abstract][Full Text] [Related]
11. Artemisinin-type drugs for the treatment of hematological malignancies.
Mancuso RI; Foglio MA; Olalla Saad ST
Cancer Chemother Pharmacol; 2021 Jan; 87(1):1-22. PubMed ID: 33141328
[TBL] [Abstract][Full Text] [Related]
12. Induction of Apoptosis, Autophagy and Ferroptosis by
N Adham A; F Hegazy ME; Naqishbandi AM; Efferth T
Molecules; 2020 Oct; 25(21):. PubMed ID: 33138135
[No Abstract] [Full Text] [Related]
13. A Nuclear Long Non-Coding RNA LINC00618 Accelerates Ferroptosis in a Manner Dependent upon Apoptosis.
Wang Z; Chen X; Liu N; Shi Y; Liu Y; Ouyang L; Tam S; Xiao D; Liu S; Wen F; Tao Y
Mol Ther; 2021 Jan; 29(1):263-274. PubMed ID: 33002417
[TBL] [Abstract][Full Text] [Related]
14. Transferrin Receptor Is a Specific Ferroptosis Marker.
Feng H; Schorpp K; Jin J; Yozwiak CE; Hoffstrom BG; Decker AM; Rajbhandari P; Stokes ME; Bender HG; Csuka JM; Upadhyayula PS; Canoll P; Uchida K; Soni RK; Hadian K; Stockwell BR
Cell Rep; 2020 Mar; 30(10):3411-3423.e7. PubMed ID: 32160546
[TBL] [Abstract][Full Text] [Related]
15. Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction.
Zhao F; Vakhrusheva O; Markowitsch SD; Slade KS; Tsaur I; Cinatl J; Michaelis M; Efferth T; Haferkamp A; Juengel E
Cells; 2020 Dec; 9(12):. PubMed ID: 33316936
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase 3a2 protects AML cells from oxidative death and the synthetic lethality of ferroptosis inducers.
Yusuf RZ; Saez B; Sharda A; van Gastel N; Yu VWC; Baryawno N; Scadden EW; Acharya S; Chattophadhyay S; Huang C; Viswanathan V; S'aulis D; Cobert J; Sykes DB; Keibler MA; Das S; Hutchinson JN; Churchill M; Mukherjee S; Lee D; Mercier F; Doench J; Bullinger L; Logan DJ; Schreiber S; Stephanopoulos G; Rizzo WB; Scadden DT
Blood; 2020 Sep; 136(11):1303-1316. PubMed ID: 32458004
[TBL] [Abstract][Full Text] [Related]
17. From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells.
Grignano E; Birsen R; Chapuis N; Bouscary D
Front Oncol; 2020; 10():586530. PubMed ID: 33042852
[TBL] [Abstract][Full Text] [Related]
18. Menin‑MLL inhibitors induce ferroptosis and enhance the anti‑proliferative activity of auranofin in several types of cancer cells.
Kato I; Kasukabe T; Kumakura S
Int J Oncol; 2020 Oct; 57(4):1057-1071. PubMed ID: 32945449
[TBL] [Abstract][Full Text] [Related]
19. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer.
Zhang H; Deng T; Liu R; Ning T; Yang H; Liu D; Zhang Q; Lin D; Ge S; Bai M; Wang X; Zhang L; Li H; Yang Y; Ji Z; Wang H; Ying G; Ba Y
Mol Cancer; 2020 Feb; 19(1):43. PubMed ID: 32106859
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
